Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
771.12 | -48,81% | -27,8% | 694.320,6 | 0,66% | 2,63% |
|
NYSE:ABBV
AbbVie
|
164.35 | -22,09% | -11,8% | 290.220,37 | 3,79% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.66 | 18,34% | 40,96% | 188.601,59 | 2,01% | 15,98% |
|
NYSE:ABT
Abbott Laboratories
|
104.87 | 1,67% | 14,31% | 182.435,39 | 2,1% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
314.72 | -12,88% | -4,16% | 168.826,73 | 2,82% | 5,31% |
|
ENXTPA:EL
EssilorLuxottica Société anonyme
|
206.40 | 15,56% | 30,29% | 93.173,1 | 1,9% | 12,87% |
|
ASX:CSL
CSL
|
286.95 | 19,62% | 40,06% | 138.669,37 | 1,25% | 7,18% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.11 | 61,44% | 71,76% | 89.415,39 | 5,39% | 13,54% |
|
NYSE:BDX
Becton Dickinson and Co
|
236.62 | 15,3% | 29,42% | 68.384,71 | 1,6% | 2,09% |
|
TSE:4568
Daiichi Sankyo Company
|
5482.00 | 0% | 0% | 10.508.692,98 | 1,09% | 0% |
|
NYSE:MMM
3M
|
104.86 | 58,61% | 73,6% | 58.025,46 | 5,97% | -2,45% |
|
XTRA:BAS
BASF
|
49.08 | 16,22% | 42,6% | 43.800,53 | 6,85% | -13,88% |
|
SWX:ALC
Alcon
|
80.88 | 8,87% | 24,16% | 39.987,07 | 0,3% | 8,65% |
|
NYSE:CTVA
Corteva
|
56.00 | 19,14% | 40,45% | 39.030,66 | 1,12% | 17,11% |
|
NasdaqGS:BIIB
Biogen
|
230.04 | -15,03% | 0,05% | 33.493,11 | 0% | -10,89% |
|
NYSE:DD
DuPont de Nemours
|
77.57 | -0,23% | 18,03% | 32.432,36 | 1,94% | -22,35% |
|
XTRA:BAYN
Bayer
|
28.65 | 67,13% | 83,44% | 28.146,45 | 0,38% | 1,47% |
|
NYSE:CHD
Church & Dwight Co Inc
|
106.68 | -12,29% | -4,72% | 26.085,71 | 1,06% | 6,91% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
151.22 | 0% | 0% | 19.128,09 | 0% | 0% |
|
TSE:4503
Astellas Pharma
|
1513.50 | 0% | 0% | 2.713.684,95 | 4,85% | 0% |
